- Home
- LX vs PAHC Comparison
LX vs PAHC Comparison
Compare LX & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LX
- PAHC
- Stock Information
- Founded
- LX 2013
- PAHC 1946
- Country
- LX China
- PAHC United States
- Employees
- LX N/A
- PAHC N/A
- Industry
- LX Finance: Consumer Services
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- LX Finance
- PAHC Health Care
- Exchange
- LX Nasdaq
- PAHC Nasdaq
- Market Cap
- LX 1.1B
- PAHC 1.2B
- IPO Year
- LX 2017
- PAHC 2014
- Fundamental
- Price
- LX $6.75
- PAHC $32.46
- Analyst Decision
- LX
- PAHC Hold
- Analyst Count
- LX 0
- PAHC 4
- Target Price
- LX N/A
- PAHC $24.50
- AVG Volume (30 Days)
- LX 4.2M
- PAHC 243.1K
- Earning Date
- LX 08-07-2025
- PAHC 09-02-2025
- Dividend Yield
- LX 5.75%
- PAHC 1.48%
- EPS Growth
- LX 86.38
- PAHC 140.17
- EPS
- LX 1.28
- PAHC 0.78
- Revenue
- LX $1,956,013,429.00
- PAHC $1,190,682,000.00
- Revenue This Year
- LX $2.38
- PAHC $28.13
- Revenue Next Year
- LX $8.71
- PAHC $13.11
- P/E Ratio
- LX $5.12
- PAHC $41.59
- Revenue Growth
- LX 0.80
- PAHC 19.12
- 52 Week Low
- LX $1.63
- PAHC $16.16
- 52 Week High
- LX $11.64
- PAHC $32.93
- Technical
- Relative Strength Index (RSI)
- LX 51.76
- PAHC 68.93
- Support Level
- LX $6.15
- PAHC $30.61
- Resistance Level
- LX $7.06
- PAHC $32.08
- Average True Range (ATR)
- LX 0.36
- PAHC 1.04
- MACD
- LX 0.03
- PAHC 0.33
- Stochastic Oscillator
- LX 68.04
- PAHC 92.89
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.